Latest news by search query "covid 19 drug interactions"

WASHINGTON - Pharmacists can prescribe the leading COVID-19 pill directly to patients under a new U.S. policy announced Wednesday that’s intended to expand use of Pfizer’s drug Paxlovid.The Food and Drug Administration said pharmacists can begin screening patients to see if they are eligible for Paxlovid and then prescribe the medication, which has been shown to curb the worst effects of COVID-19.

Usa Washington North Korea covid-19 testing patient

Gilead’s revenue declines on waning sales of Covid-19 drug

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

India covid-19 information

New COVID-19 drug approved that can treat and prevent COVID-19

The Ministry of Health’s medicine regulatory arm Medsafe, today approved a new COVID-19 medicine Ronapreve that can both prevent and treat COVID-19 though it is not a substitute for vaccination and its effectiveness against the latest variant of concern is yet to be demonstrated.

Chris James covid-19 vaccine medicines

Health Canada considers Merck’s experimental COVID-19 drug

As COVID-19 patients swamp intensive care units, Health Canada is now reviewing Molnupiravir, an experimental drug claiming to reduce the disease’s worst outcomes. Jamie Mauracher looks at what we know and don’t know about this pill.

Jamie Mauracher Canada covid-19 patient Health

Merck to seek EAU for experimental Covid-19 drug molnupiravir

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

India covid-19 information

Experimental pill fights COVID-19, drug-maker Merck claims

experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use.If cleared, Merck’s drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic.

hospital covid-19 patient

India's Cipla says supply of COVID-19 drug remdesivir catching up with demand

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

India covid-19 information

Chinese firm's COVID-19 drug claims draw skepticism

COVID-19 treatment.It was the company's latest announcement about the progress of the drug, Proxalutamide. The Hong Kong-listed company's stock price has nearly quadrupled since March 1 as some analysts wrote about the big sales potential for a COVID-19 treatment.

China India Hong Kong covid-19 information patient

Dr Reddy's signs pact with Eli Lilly to produce Covid treatment drug in India

Eli Lilly and Company for the manufacture and commercialization of Baricitinib in India, the Hyderabad-based pharma company said on Tuesday.Baricitinib has received restricted emergency use approval from the Central Drugs Standard Control Organisation (CDSCO) for use in combination with Remdesivir.The drug is to be used in the treatment of suspected or laboratory-confirmed Covid-19 infections in hospitalised adults requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO)."This partnership comes at a critical juncture in the fight against the pandemic in India, and adds to the company’s existing range of Covid-19 therapeutics covering the full spectrum from mild to moderate and severe

India city Hyderabad covid-19 pandemic patient

Analysis spotlights shortage of a COVID-19 drug in Canada

Tocilizumab, like other potential COVID-19 drug treatments, is in spot shortages around the world.

India Britain Canada hospital covid-19 patient Analysis

MSD Pharma signs pact with 5 Indian firms to make investigational covid-19 drug

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

India covid-19

Drugmakers slash prices of covid-19 drug remdesivir

₹899-3,490 per vial from the earlier price of ₹2,800-5,400 per vial NEW DELHI : Seven pharmaceutical companies which manufacture remdesivir in India have slashed the prices of the drug, given to patients with severe covid-19 in hospitals, by at least a fourth after the government urged them to do it.The seven companies—Cadila Healthcare, Syngene International, Dr Reddy's Laboratories, Cipla, Viatris (which was earlier Mylan), Jubilant Generics and Hetero Healthcare—are contract manufacturers of the intravenous drug through a voluntary licensing agreement with its US-based innovator Gilead Sciences Inc.The companies will now be selling the drug in the range of ₹899-3,490 per vial from the earlier price of 2,800-5,400 per vial.Cadila

city New Delhi Usa India covid-19 Government patient

Hinshaw, Shandro to provide provincial COVID-19 update Tuesday afternoon

COVID-19 in the province and “the ongoing work to protect public health.”The chief medical officer of health and minister will be making their comments at 4 p.m. and you can watch them in this story.

Deena Hinshaw Tyler Shandro Alberta Covid Alberta Coronavirus province Covid covid-19 Coronavirus

World’s largest COVID-19 drug trial identifies second compound that cuts risk of death

Kai KupferschmidtScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.The world’s largest trial of COVID-19 drugs has produced more good news: The anti-inflammatory drug tocilizumab cut the death risk of people hospitalized with the disease, reduced their need for a mechanical ventilator, and shortened time spent in the hospital, investigators of the United Kingdom’s Recovery trial announced today at a press conference. A preprint about the data has been published on medRxiv.“This is an incredibly significant result,” says Athimalaipet Ramanan, a rheumatologist at the University of Bristol who was not involved in the study but sits on the steering committee of a tocilizumab trial in India.

India Britain city Bristol covid-19 death patient

Ontario doctors urge domestic drug manufacturing over fears of shortages due to pandemic

COVID-19 cases and hospital admissions could limit drug supplies in coming weeks.OMA president Dr. Samantha Hill said chronic drug shortages have worsened during the pandemic and may become more serious if hospitals are overwhelmed.That includes essential and critical care medications propofol, ketamine, succinylcholine, fentanyl, and midazolam.“Drug shortages can be catastrophic for patients, causing treatment delays, increased suffering, financial burden and an increased risk of overdose and underdose,” Hill said Tuesday in a release.

covid-19 Drugs Coronavirus

Ocala company reveals new COVID-19 drug for virus ‘long haulers’

OCALA, Fla. – There’s a new COVID-19 drug in town and the company behind it hopes the treatment will help those suffering from post-COVID-19 infection chronic fatigue-like symptoms, who have been dubbed “long haulers.”AIM ImmunoTech Inc. announced Wednesday that they officially provide the first dose to their first patient with the drug called Ampligen.[TRENDING: How to get vaccine in Fla. | Publix to offer vaccine | Man sends dead rat to ex-wife | Dr. Dre suffers brain aneurysm]The company believes this to be the first clinical trial to treat a patient with COVID-19-induced chronic fatigue-like symptoms.“AIM is committed to helping the untold number of people who are already dealing with the long-term effects of COVID-19 infection,” AIM

virus covid-19 patient

'Exciting' new Covid-19 drug on trial could provide instant immunity against virus

Covid-19 believe they have developed a new drug that can provide “instant immunity” from coronavirus.For people who have already been exposed to the virus, a vaccine would not be effective but the experts from the University College Hospitals NHS Trust (UCLH) in London say their revolutionary antibody treatment, dubbed “Storm Chaser,” could be a life-saver for people in the early stages of infection.Dr Catherine Houlihan, one of the virologists working on Storm Chaser, said: “If we can prove that this treatment works and prevent people who are exposed to the virus going on to develop Covid-19, it would be an exciting addition to the arsenal of weapons being developed to fight this dreadful virus.”10 volunteers have already been injected

city London virus covid-19 outbreak

New research suggests Alberta COVID-19 R value currently too high to lift restrictions

new measures announced on Nov. 24.[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]Kenney said the province’s R value must be below one by Dec.

Alberta Covid Alberta Coronavirus province Covid covid-19 Alberta COVID-19 Alberta Government Coronavirus

AstraZeneca’s covid antibody drug moves into advanced trials

AstraZeneca Plc started late-stage trials for an antibody medicine against Covid-19 after President Donald Trump credited a similar therapy with aiding his recovery. Eli Lilly & Co.

Donald Trump Eli Lilly Usa covid-19 Government prevention medicines

India, South Africa ask WTO to waive rules to aid COVID-19 drug production

VIENNA : India and South Africa want the World Trade Organization (WTO) to waive intellectual property rules to make it easier for developing countries to produce or import COVID-19 drugs, a letter to the WTO shows.In their letter dated Oct.

India South Africa city Vienna covid-19 pandemic vaccine Government

UBC professor uses knowledge of SARS to develop COVID-19 drug

COVID-19.Dr. Josef Penninger, a UBC life sciences institute director, co-discovered an enzyme called ACE2 while working as a researcher in Toronto in the late ’90s.A few years later, during the SARS epidemic, Penninger discovered that ACE2 was the virus’ gateway into healthy cells, where they both replicated and destroyed tissue.

covid-19 Sars Coronavirus

Fusion Health Care launches COVID-19 drug Favipiravir and an immunity booster

[email protected]: This content is distributed by Business Wire India. No HT journalist is involved in creation of this content.Click here to read the Mint ePaperLivemint.com is now on Telegram.

India covid-19

B.C. government doubling youth treatment beds as illicit drug overdose deaths continue to climb

ongoing pandemic due to an increase in toxic drug supplies and more drug users being home and alone.In total there will be 123 new beds from people aged 12 to 24. They will be for youth substance-use treatment and withdrawal management.The money won’t be available right away, with the improvement earmarked to come in from now until 2022-23.

covid-19 Drugs overdoses Coronavirus

Glenmark defends price of its covid-19 drug favipiravir version

BENGALURU : Glenmark Pharmaceuticals Ltd defended the pricing of its generic version of favipiravir, FabiFlu, on Tuesday, after India's drug regulator had reportedly sent the company a notice on overpricing.Shares of the Mumbai-based company fell as much as 5.8% on Monday after local media reports said the Drug Controller General of India (DCGI) pulled up Glenmark regarding the price of the tablet and other concerns."Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option," the company said in a statement to the exchanges.Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.FabiFlu's price

India city Mumbai covid-19 information

DCGI pulls up Glenmark for false claims, overpricing of covid-19 drug FabiFlu

₹103 per tablet of 200 mg during its launch, and an entire two-week course of treatment required 122 tablets, leading to a total cost of ₹12,500. It had, however, last week, slashed the price by 27% to ₹75 per pill, or ₹9,150 for the course.Somani, who heads the country’s apex regulatory body Central Drugs Standards Control Organisation (CDSCO), has asked the company to provide a clarification on the matter.

hospital covid-19 symptoms patient

pharmaceutical-technology.com

06.07.2020 / 14:09

41%

318

Medivir and SciLifeLab partner to identify Covid-19 drug candidates

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Swedish drug development company Medivir has partnered with SciLifeLab, a life science research firm, to identify compounds with the potential to inhibit SARS-CoV-2, the novel coronavirus that causes Covid-19. The research collaboration will involve SciLifeLab’s Drug Discovery and Development Platform (DDD), which will gain access to Medivir’s protease-targeted compound library.

Sweden virus covid-19 pneumonia

pharmaceutical-technology.com

02.07.2020 / 12:15

48%

721

Road to RECOVERY: A deep dive into the world’s largest Covid-19 drug trial

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.“Around 9 or 10 March, it become obvious that [the novel] coronavirus was going to be a major challenge worldwide. First of all, [because] there are no known treatments.

Peter Horby Martin Landray city Oxford covid-19 medicines patient

Pfizer shares jump 9% as parent's potential covid-19 drug shows positive result

₹4172.60 on Thursday after the company's US-based parent reported positive preliminary results from a joint project to develop coronavirus vaccine.At 12:30 pm, Pfizer shares were at ₹4163.95, up 4.76% from the previous close, while the benchmark index, Sensex gained 1.25% to 35856.53.BioNTech and Pfizer pick the most promising of four experimental vaccines for a trial, involving up to 30,000 healthy participants, that is likely to begin in the United States and Europe in late July, if it gets the regulatory green light. The study of Pfizer's and BioNtech's vaccine candidate, called BNT162b1, is undergoing scientific peer review.

Usa covid-19 vaccine Coronavirus

UK insists it has enough remdesivir after Trump buys up global supplies of Covid-19 drug

The UK has enough stocks of the drug remdesivir after the US sparked anger, buying nearly all the stock for the next three months.

Matt Hancock Usa Britain covid-19 patient Coronavirus

Donald Trump buys up virtually all stocks of working Covid-19 drug remdesivir

Donald Trump has bought up virtually all stocks for the next three months of a drug shown to work against Covid-19.

Donald Trump Usa Britain covid-19 Department patient

pharmaceutical-technology.com

29.06.2020 / 16:01

90%

851

Gilead sets Covid-19 drug candidate remdesivir price at $390 per vial

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.Gilead Sciences has set the price of its investigational Covid-19 drug remdesivir at $390 per vial for the US and governments of other developed countries. Current treatment patterns reveal that most patients may require a five-day treatment course, which involves six vials of remdesivir, pricing the course at $2,340 per patient.

Daniel Oday Usa covid-19 Government Department patient

pharmaceutical-technology.com

28.06.2020 / 13:25

77%

520

FDA grants fast track status to NeuroRx’s Covid-19 drug candidate

NeuroRx CEO and chairman Jonathan Javitt said: “We at NeuroRx are enormously appreciative of the FDA’s commitment to accelerating the development of any potential treatment for Covid-19. We hope to live up to the trust that has been placed in us by bringing a life-saving treatment to patients.” The Phase II / III trials of RLF-100 are being performed at multiple medical centres, including the University of Miami, Houston Methodist Hospital, University of California-Irvine, NYU Langone Medical Center, and Rambam Healthcare Campus in Haifa, Israel.

Israel state California county Miami hospital covid-19 patient track

pharmaceutical-technology.com

24.06.2020 / 13:15

67%

792

FDA grants fast track status to NeuroRx’s Covid-19 drug candidate

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The US Food and Drug Administration (FDA) has granted fast track designation to RLF-100 (Aviptadil), which is being developed by NeuroRx and Relief Therapeutics to treat acute lung injury / acute respiratory distress syndrome caused by Covid-19. RLF-100 is a synthetic version of human Vasoactive Intestinal Peptide (VIP), which decreases inflammation in the lungs.

Usa hospital covid-19 patient track

Zydus Cadila signs licensing pact with Gilead for covid-19 drug remdesivir

NEW DELHI : Zydus Cadila on Friday announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and sale of the promising covid-19 drug remdesivir.This makes Zydus Cadila the fifth company in India and sixth in the world to sign licensing agreement for Gilead’s novel intravenous drug, which has received emergency use authorisation (EUA) in both the US, India and a few other countries for the treatment of covid-19.Last month, Gilead Sciences Inc signed non-exclusive voluntary licensing agreements with five generic pharmaceutical manufacturers – Cipla Ltd, Jubilant Life Sciences, Hetero Labs Ltd, Mylan and Ferozsons Laboratories – on a royalty-free basis.Of the five, Ferozsons Laboratories is

city New Delhi Usa India covid-19 Ventilators patient

Emails offer look into whistleblower charges of cronyism behind potential COVID-19 drug

Rick Bright's whistleblower complaint argues that federal officials inappropriately tried to steer U.S. money to an unproven treatment for the pandemic coroanvirus

virus covid-19 pandemic

Glenmark starts clinical trial of potential covid-19 drug favipiravir in India

NEW DELHI: Glenmark Pharmaceuticals Ltd has initiated phase 3 clinical trials in India on the use of generic antiviral drug favipiravir for treatment of mild to moderate covid-19, a study which the Mumbai-based drug-maker expects to complete by August.

Japan city New Delhi India city Mumbai hospital covid-19 Government patient

Gilead says in talks with India for making Covid-19 drug remdesivir

Gilead Sciences Inc said on Tuesday it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022.

India virus covid-19 outbreak patient

Bangladesh's Beximco to start Covid-19 drug remdesivir production this month

NEW DELHI : One of Bangladesh's largest drugmakers, Beximco Pharmaceuticals, will start production this month of the experimental antiviral drug remdesivir, which has shown promise in fighting the new coronavirus, a senior company executive said on Tuesday.

Gilead Sciences city New Delhi Usa Bangladesh covid-19 Government patient Coronavirus

pharmaceutical-technology.com

05.05.2020 / 14:57

83%

785

Eli Lilly signs Covid-19 drug development deal with Junshi Biosciences

Eli Lilly has signed an agreement with China-based biopharmaceutical firm Junshi Biosciences to jointly develop therapeutic antibodies to prevent and treat Covid-19.

Eli Lilly China covid-19 testing prevention infection

Global COVID-19 drug and vaccine push nets $8 billion from donors

Ten days ago the World Health Organization (WHO) and its partners announced a massive effort to scale up development and production of COVID-19 vaccines, treatments, and tests and ensure that they're equitably distributed, and today countries and groups pledged $8 billion to make the plan—called the ACT Accelerator—a reality.

covid-19 testing

US emergency approval broadens use of Gilead's COVID-19 drug remdesivir

During a meeting in the Oval Office of the White House with President Donald Trump, Gilead Chief Executive Daniel O'Day called the move an important first step and said the company was donating 1.5 million vials of the drug to help patients.

Donald Trump Daniel Oday Usa Washington hospital covid-19 donates patient

Coronavirus outbreak: Trump, Fauci hopeful about Gilead’s COVID-19 drug Remdesivir

Dr. Anthony Fauci, the director of the U.S.

Anthony Fauci covid-19 outbreak Coronavirus

Dow ends up 2.2% on optimism over Covid-19 drug, Fed stimulus

NEW YORK, April 29 (Reuters) - U.S. stocks surged on Wednesday as hopes for an effective COVID-19 treatment prompted a broad rally and helped investors shrug off bleak GDP data and words of warning from U.S. Federal Reserve Chair Jerome Powell.

U.S.Federal New York county Jerome city Powell, county Jerome covid-19 economy Department

Gilead disputes report that its Covid-19 drug remdesivir flopped in leaked trial

A closely-watched Gilead Sciences Inc experimental antiviral drug failed to help patients with severe COVID-19 in a clinical trial conducted in China, but the drugmaker said the findings were inconclusive because the study was terminated early.

China city Chicago hospital covid-19 patient

pharmaceutical-technology.com

22.04.2020 / 09:21

90%

272

SOM Biotech identifies three Covid-19 drug candidates

SOM Biotech has completed in-vitro analyses and identified three drug candidates that can be potentially used to treat Covid-19.

South Korea covid-19 pandemic innovations Coronavirus

pharmaceutical-technology.com

21.04.2020 / 17:47

92%

745

RedHill Biopharma partners with NIAID for potential Covid-19 drug

Israel-based RedHill Biopharma has partnered with the US National Institute of Allergy and Infectious Diseases (NIAID) to study its RHB-107 (upamostat, WX-671) drug candidate in non-clinical tests for the treatment of Covid-19.

Usa Israel covid-19 pneumonia testing patient

pharmaceutical-technology.com

03.04.2020 / 13:31

75%

232

Amgen and Adaptive Biotechnologies to develop Covid-19 drug

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

virus covid-19 infection medicines

pharmaceutical-technology.com

20.03.2020 / 17:05

81%

403

Ridgeback Biotherapeutics and DRIVE to develop Covid-19 drug

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

virus covid-19 innovations

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0

Latest news by search query "covid 19 drug interactions"

Related News